Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Miraculum

WSE:MIR
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MIR
WSE
PLN47M
Market Cap
  1. Home
  2. PL
  3. Household
Company description

Miraculum S.A., a cosmetics company, develops and markets face and body care, perfume, depilation, and make-up products for men and women in Poland and internationally. The last earnings update was 136 days ago. More info.


Add to Portfolio Compare Print
  • Miraculum has significant price volatility in the past 3 months.
MIR Share Price and Events
7 Day Returns
35.9%
WSE:MIR
31.7%
PL Personal Products
0.9%
PL Market
1 Year Returns
-6%
WSE:MIR
-13.7%
PL Personal Products
-33.2%
PL Market
MIR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Miraculum (MIR) 35.9% 2.2% 9.8% -6% -30% 21.1%
PL Personal Products 31.7% 19.5% 0.7% -13.7% -60.1% 17.7%
PL Market 0.9% -18.9% -28.2% -33.2% -38% -39%
1 Year Return vs Industry and Market
  • MIR outperformed the Personal Products industry which returned -13.7% over the past year.
  • MIR outperformed the Market in Poland which returned -33.2% over the past year.
Price Volatility
MIR
Industry
5yr Volatility vs Market

Value

 Is Miraculum undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Miraculum. This is due to cash flow or dividend data being unavailable. The share price is PLN1.4.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Miraculum's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Miraculum's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WSE:MIR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in PLN PLN-0.09
WSE:MIR Share Price ** WSE (2020-04-03) in PLN PLN1.4
Europe Personal Products Industry PE Ratio Median Figure of 28 Publicly-Listed Personal Products Companies 21.11x
Poland Market PE Ratio Median Figure of 421 Publicly-Listed Companies 9.34x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Miraculum.

WSE:MIR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= WSE:MIR Share Price ÷ EPS (both in PLN)

= 1.4 ÷ -0.09

-15.96x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Miraculum is loss making, we can't compare its value to the Europe Personal Products industry average.
  • Miraculum is loss making, we can't compare the value of its earnings to the Poland market.
Price based on expected Growth
Does Miraculum's expected growth come at a high price?
Raw Data
WSE:MIR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -15.96x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Personal Products Industry PEG Ratio Median Figure of 14 Publicly-Listed Personal Products Companies 1.39x
Poland Market PEG Ratio Median Figure of 102 Publicly-Listed Companies 0.73x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Miraculum, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Miraculum's assets?
Raw Data
WSE:MIR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in PLN PLN0.67
WSE:MIR Share Price * WSE (2020-04-03) in PLN PLN1.4
Poland Personal Products Industry PB Ratio Median Figure of 7 Publicly-Listed Personal Products Companies 1.6x
Poland Market PB Ratio Median Figure of 638 Publicly-Listed Companies 0.84x
WSE:MIR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= WSE:MIR Share Price ÷ Book Value per Share (both in PLN)

= 1.4 ÷ 0.67

2.09x

* Primary Listing of Miraculum.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Miraculum is overvalued based on assets compared to the PL Personal Products industry average.
X
Value checks
We assess Miraculum's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Miraculum has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Miraculum expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Miraculum has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.2%
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Miraculum expected to grow at an attractive rate?
  • Unable to compare Miraculum's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Miraculum's earnings growth to the Poland market average as no estimate data is available.
  • Unable to compare Miraculum's revenue growth to the Poland market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
WSE:MIR Future Growth Rates Data Sources
Data Point Source Value (per year)
Europe Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 9.2%
Europe Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
Poland Market Earnings Growth Rate Market Cap Weighted Average 11.9%
Poland Market Revenue Growth Rate Market Cap Weighted Average 4.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WSE:MIR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in PLN Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WSE:MIR Past Financials Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income *
2019-09-30 21 -5 -3
2019-06-30 21 -5 -5
2019-03-31 21 -5 -5
2018-12-31 22 -4 -4
2018-09-30 22 -4 -8
2018-06-30 22 -12 -9
2018-03-31 22 -14 -9
2017-12-31 20 -14 -11
2017-09-30 20 -13 -15
2017-06-30 25 -4 -13
2017-03-31 29 -1 -17
2016-12-31 32 -3 -15

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Miraculum is high growth as no earnings estimate data is available.
  • Unable to determine if Miraculum is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WSE:MIR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Miraculum Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:MIR Past Financials Data
Date (Data in PLN Millions) EPS *
2019-09-30 -0.09
2019-06-30 -0.16
2019-03-31 -0.17
2018-12-31 -0.15
2018-09-30 -0.45
2018-06-30 -0.38
2018-03-31 -0.47
2017-12-31 -0.69
2017-09-30 -0.79
2017-06-30 -1.13
2017-03-31 -1.55
2016-12-31 -1.48

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Miraculum will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Miraculum's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  2. Miraculum's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Miraculum's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Miraculum has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Miraculum performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Miraculum's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Miraculum does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Miraculum's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Miraculum's 1-year growth to the Europe Personal Products industry average as it is not currently profitable.
Earnings and Revenue History
Miraculum's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Miraculum Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:MIR Past Revenue, Cash Flow and Net Income Data
Date (Data in PLN Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 21.43 -2.84 12.31
2019-06-30 21.05 -4.97 12.04
2019-03-31 20.73 -4.80 11.50
2018-12-31 22.24 -4.05 11.46
2018-09-30 21.87 -7.96 13.14
2018-06-30 21.98 -8.61 13.70
2018-03-31 21.85 -9.05 14.49
2017-12-31 20.21 -11.19 15.05
2017-09-30 19.68 -15.02 15.24
2017-06-30 25.16 -13.02 15.86
2017-03-31 28.66 -17.16 17.21
2016-12-31 32.18 -15.44 17.20
2016-09-30 35.98 -7.35 17.33
2016-06-30 33.85 -8.24 16.96
2016-03-31 32.21 -4.10 16.11
2015-12-31 30.97 -3.04 15.73
2015-09-30 34.80 -1.70 15.22
2015-06-30 31.61 -2.84 14.58
2015-03-31 33.12 -0.81 15.05
2014-12-31 34.77 -1.20 15.76
2014-09-30 31.71 -2.12 16.09
2014-06-30 34.19 -1.62 16.60
2014-03-31 36.30 -2.73 16.78
2013-12-31 35.65 -4.13 16.93
2013-09-30 37.08 -18.19 21.35
2013-06-30 44.52 -20.02 25.48

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Miraculum has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Miraculum has efficiently used its assets last year compared to the Europe Personal Products industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Miraculum improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Miraculum's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Miraculum has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Miraculum's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Miraculum's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Miraculum's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Miraculum's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Miraculum's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Miraculum Company Filings, last reported 6 months ago.

WSE:MIR Past Debt and Equity Data
Date (Data in PLN Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 22.58 14.48 0.26
2019-06-30 21.52 13.05 0.81
2019-03-31 21.10 15.64 0.40
2018-12-31 22.45 15.17 1.76
2018-09-30 22.94 17.86 5.01
2018-06-30 13.52 22.20 0.15
2018-03-31 14.66 22.00 0.92
2017-12-31 14.36 21.39 1.48
2017-09-30 16.48 21.13 0.24
2017-06-30 0.94 27.49 0.15
2017-03-31 2.52 24.38 0.32
2016-12-31 5.25 22.09 0.30
2016-09-30 19.54 24.12 0.22
2016-06-30
2016-03-31 13.98 24.17 0.20
2015-12-31 14.99 21.96 1.65
2015-09-30 17.08 28.97 0.55
2015-06-30 17.20 25.09 0.17
2015-03-31 17.99 30.07 1.12
2014-12-31 17.17 30.22 1.23
2014-09-30 17.86 35.26 2.74
2014-06-30 19.61 34.44 2.78
2014-03-31 19.67 29.17 0.54
2013-12-31 18.32 26.50 0.71
2013-09-30 17.67 23.82 0.24
2013-06-30 7.34 32.47 0.31
  • Miraculum's level of debt (61.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (191.5% vs 61.9% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Miraculum has less than a year of cash runway based on current free cash flow.
  • Miraculum has less than a year of cash runway if free cash flow continues to grow at historical rates of 21.5% each year.
X
Financial health checks
We assess Miraculum's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Miraculum has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Miraculum's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Miraculum dividends.
If you bought PLN2,000 of Miraculum shares you are expected to receive PLN0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Miraculum's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Miraculum's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WSE:MIR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 2.5%
Poland Market Average Dividend Yield Market Cap Weighted Average of 195 Stocks 5.9%
Poland Minimum Threshold Dividend Yield 10th Percentile 1.5%
Poland Bottom 25% Dividend Yield 25th Percentile 3.1%
Poland Top 25% Dividend Yield 75th Percentile 8.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Miraculum has not reported any payouts.
  • Unable to verify if Miraculum's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Miraculum's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Miraculum has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Miraculum's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.5%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Miraculum afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Miraculum has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Miraculum's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Miraculum has no CEO, or we have no data on them.
Management Team

Anna Stenszke

TITLE
Vice Chairman of the Management Board and Finance Director
TENURE
7.4 yrs

Urszula Grzegorzewska

TITLE
COMPENSATION
PLN29K

Aneta Klimek

TITLE
Director of Finance
TENURE
6.9 yrs

Anna Pacocha

TITLE
Chief Accountant

Joanna Jeziorowska

TITLE
Human Resource Director
Board of Directors

Grzegorz Golec

TITLE
Chairman of Supervisory Board

Slawomir Ziemski

TITLE
Vice-Chairman of Supervisory Board

Tadeusz Tuora

TITLE
Deputy Chairman of Supervisory Board

Janusz Auleytner

TITLE
Member of the Supervisory Board

Robert Ciszek

TITLE
Member of the Supervisory Board

Andrzej Kopka

TITLE
Member of the Supervisory Board

Grzegorz Kubica

TITLE
Member of the Supervisory Board

Anna Scibisz

TITLE
Member of the Board

Piotr Skowron

TITLE
Member of Supervisory Board

Jan Zalubski

TITLE
Member of Supervisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (PLN) Value (PLN)
X
Management checks
We assess Miraculum's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Miraculum has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Those Who Purchased Miraculum (WSE:MIR) Shares Five Years Ago Have A 60% Loss To Show For It

Check out our latest analysis for Miraculum Miraculum isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. … In the last five years Miraculum saw its revenue shrink by 12% per year. … We would want clear information suggesting the company will grow, before taking the view that the share price will stabilize.

Simply Wall St -

Miraculum S.A. (WSE:MIR): Time For A Financial Health Check

(WSE:MIR) is a small-cap stock with a market capitalization of zł47m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

Are Miraculum SA's (WSE:MIR) Interest Costs Too High?

Investors are always looking for growth in small-cap stocks like Miraculum SA (WSE:MIR), with a market cap of zł38.50m. … However, an important fact which most ignore is: how financially healthy is the business?

Simply Wall St -

How Does Miraculum SA. (WSE:MIR) Affect Your Portfolio Returns?

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … MIR’s beta indicates it is a stock that investors may find valuable if they want to reduce the overall market risk exposure of their stock portfolio. … I examine MIR’s ratio of fixed assets to total assets to see whether the company is highly exposed to the risk of this type of constraint.

Simply Wall St -

What Does Miraculum SA.'s (WSE:MIR) Ownership Structure Look Like?

I am going to take a deep dive into Miraculum SA.’s (WSE:MIR) most recent ownership structure, not a frequent subject of discussion among individual investors. … Insider Ownership I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. … As a result, potential investors should further explore the company's business relations with these companies and find out if they can affect shareholder returns in the long-term.Next Steps: With a low level of institutional ownership, investors in MIR need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.

Simply Wall St -

How Much Cash Is Left In The Bank For Miraculum SA. (WSE:MIR)?

The single most important question to ask when you’re investing in a loss-making company is – will they need to raise cash again, and if so, when? … Looking at Miraculum’s latest financial data, I will gauge when the company may run out of cash and need to raise more money. … WSE:MIR Income Statement Mar 28th 18 When will Miraculum need to raise more cash?

Simply Wall St -

Is Miraculum SA.'s (WSE:MIR) Balance Sheet A Threat To Its Future?

How does MIR’s operating cash flow stack up against its debt? … At this current level of debt, MIR's cash and short-term investments stands at ZŁ296.17K , ready to deploy into the business. … Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.Next Steps: With a high level of debt on its balance sheet, MIR could still be in a financially strong position if its cash flow also stacked up.

Simply Wall St -

Does Miraculum SA.'s (WSE:MIR) Past Performance Indicate A Weaker Future?

After reading Miraculum SA.'s (WSE:MIR) most recent earnings announcement (30 September 2017), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … WSE:MIR Income Statement Mar 12th 18 We can further examine Miraculum's loss by looking at what the industry has been experiencing over the past few years. … Each year, for the past five years Miraculum has seen an annual decline in revenue of -7.83%, on average.

Simply Wall St -

Company Info

Description

Miraculum S.A., a cosmetics company, develops and markets face and body care, perfume, depilation, and make-up products for men and women in Poland and internationally. The company also offers shaving products and deodorants. It provides its products primarily under the Pani Walewska, Miraculum, Gracja, Tanita, Paloma, Lider, Wars, and Byc Moze. The company was founded in 1924 and is based in Warsaw, Poland.

Details
Name: Miraculum S.A.
MIR
Exchange: WSE
Founded: 1924
PLN47,110,000
33,650,000
Website: http://www.miraculum.pl
Address: Miraculum S.A.
ul. Aleje Jerozolimskie 184 B,
Warsaw,
02-486,
Poland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
WSE MIR Common Bearer Shares Warsaw Stock Exchange PL PLN 16. Apr 2007
LSE 0OAU Common Bearer Shares London Stock Exchange GB PLN 16. Apr 2007
Number of employees
Current staff
Staff numbers
0
Miraculum employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/04 22:50
End of day share price update: 2020/04/03 00:00
Last earnings filing: 2019/11/20
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.